Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Post by besttobeon Sep 23, 2021 11:42am
209 Views
Post# 33905110

HME article rising costs

HME article rising costs

VGM HIGHLIGHTS INCREASING COSTS IN LETTER TO CMS‘THE HME PROVIDER COMMUNITY NEEDS HELP IN THE FORM OF HIGHER REIMBURSEMENT RATES, AND THEY NEED IT IMMEDIATELY’ 

Clint GeffertWATERLOO, Iowa – VGM & Associates has sent a letter asking CMS, at minimum, to pay all HME providers in non-rural areas, including those in the 130 competitive bidding areas, the 75/25 blended reimbursement rates to help them offset increasing costs. 

“Since the onset of the COVID-19 pandemic, acquisition costs for many products have been rising steadily in the form of incremental price increases,” writes Clint Geffert, president of VGM & Associates in the Sept. 8 letter. “Fuel costs, delivery vehicle costs and labor costs have also been on the rise. Now, within the last few weeks, several major manufacturers of DME have announced yet another round of surcharges that have already been implemented or will be implemented within the next few weeks. The DME supplier community cannot absorb these price increases and continue to provider products to Medicare beneficiaries.” 

Only providers in non-rural, non-bid areas currently receive the 75/25 blended reimbursement rates through the public health emergency. 

That means, VGM points out, that providers in bid areas are receiving reimbursement that is: 1) tied to previous rounds of bidding; 2) derived via an auction methodology using a “median bid” vs. a clearing price; and 3) based on pre-pandemic demand and cost structure. 

“The HME provider community needs help in the form of higher reimbursement rates, and they need it immediately,” Geffert writes. 


<< Previous
Bullboard Posts
Next >>